Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma

Annals of Hematology

Volumn 82, Issue 12, 2003, Pages 743-749

  Mandigers, C M P W ^a,d   Meijerink, J P P ^a,b   van't Veer, M B ^c   Mensink, E J B M ^a   Raemaekers, J M M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Follicular lymphoma; Real time quantitative PCR; t(14; 18)

Indexed keywords

ALPHA2B INTERFERON; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; STEROID; TUMOR MARKER; VINCRISTINE;

ARTICLE; BONE MARROW DISEASE; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 14; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL COUNT; CHEMOTHERAPY, ADJUVANT; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; CYTODIAGNOSIS; DISEASE-FREE SURVIVAL; HUMANS; LYMPHOMA, FOLLICULAR; NEOADJUVANT THERAPY; NEOPLASM CIRCULATING CELLS; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 0346258161     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0762-6     Document Type: Article

References (26)

1. Apostolidis J, Gupta R, Grenzelias D, Johnson P, Pappa V, Summers K, Salam A, Adams K, Norton AJ, Amess J, Matthews J, Bradburn M, Lister T, Rohatiner A (2000) High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. J Clin Oncol 18:527-536
2. Cheson B, Horning S, Coiffier B, Shipp M, Fisher R, Connors J, Lister T, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris N, Armitage J, Carter W, Hoppe R, Canellos G (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 17:1244-1253
3. Colombat P, Salles G, Brousse N, Eftekhari P, Soubeyran P, Delwail V, Deconinck E, Haïoun C, Foussard C, Sebban C, Stamatoullas A, Milpied N, Boué F, Taillan B, Lederlin P, Najman A, Thièblemont C, Montestruc F, Mathieu-Boué A, Benzohra A, Solal-Céligny P (2001) Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 97:101-106
4. Czucman M, Grillo-López A, McLaughlin P, White C, Saleh M, Gordon L, LoBuglio A, Rosenberg J, Alkuzweny B, Maloney D (2001) Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy. Ann Oncol 12:109-114
5. Drillenburg P, Pals S (2000) Cell adhesion receptors in lymphoma dissemination (review). Blood 95:1900-1910
6. Freedman A, Gribben J, Neuberg D, Mauch P, Soiffer R, Anderson K, Pandite L, Robertson M, Kroon M, Ritz J, Nadler L (1996) High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 88:2780-2786
7. Hardingham J, Kotasek D, Sage R, Gooley L, Mi J-X, Dobrovic A, Norman J, Bolton A, Dale B (1995) Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 13:1073-1079
8. Heid C, Stevens J, Livak K, Williams P (1996) Real-time quantitative PCR. In: Genome methods. Genome Research. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 986-994
9. Hirt C, Dölken G (2000) Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplant 25:419-426
10. Ho A, Devereux S, Mufti G, Pagliuca A (2003) Reduced intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions. Bone Marrow Transplant 31:551-557
11. Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M, Brugiatelli M, Coser P, Pernotti A, Majolino I, Fioritoni G, Moranti S, Musso M, Zimbello R, Chisesi T, Di Renzo N, Vivaldi P, De Crescenzo A, Gallamini A, Salvi F, Santini G, Boccomini C, Sorio M, Astolfi M, Drandi D, Pileri A Tarella C (2002) High rate of clinical remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood 100:1559-1565
12. Lambrechts A, Hupkes P, Dorssers L, Van 't Veer M (1994) Clinical significance of t(14;18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 12:1541-1546
13. Limpens J, Stad R, Vos C, De Vlaam C, De Jong D, Van Ommen G, Schuuring E, Kluin P (1995) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528-2536
14. López-Guillermo A, Cabanillas F, McLaughlin P, Smith T, Hagemeister F, Rodríguez M, Romaguera J, Younes A, Sarris A, Preti H, Pugh W, Lee M (1998) The clinical significance of molecular response in indolent follicular lymphomas. Blood 91:2955-2960
15. Mandigers, C, Meijerink J, Raemaekers J, Schattenberg A, Mensink E (1998) Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18). Lancet 352:1522-1523
16. Mandigers C, Meijerink J, Mensink E,, Tönnissen E, Hebeda K, Bogman M, Raemaekers J, on behalf of the Interzol (South-East Netherlands Comprehensive Cancer Centers Cooperative Group) (2001) Lack of correlation between numbers of circulating t(14;18) positive cells and response to first-line treatment in follicular lymphoma. Blood 98:940-944
17. Mandigers C, Verdonck L, Meijerink J, Dekker A, Schattenberg A, Raemaekers J (2003) Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic: stem cell transplantation. Bone Marrow Transplant, in press
18. Meijerink J, Goverde G, Smetsers T, Raemaekers J, Bogman M, de Witte T, Mensink E (1994) Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation. Ann Oncol 5:S43-S45
19. Montoto S, Lopez-Guillermo A, Colomer D, Esteve J, Bosch F, Ferrer A, Villamor N, Moreno C, Campo E, Montserrat E (2003) Incidence and clinical significance of bcl-2/IgH rearangements in follicular lymphoma. Leuk Lymphoma 44:71-76
20. Price C, Meerabux J, Murtagh S, Cotter F, Rohatiner A, Young B, Lister T (1991) The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 9:1527-1532
21. Rambaldi A, Lazzari M, Manzoni C, Carlotti E, Arcaini L, Baccarani M, Barbui T, Bernasconi C, Dastoli G, Fuga G, Gamba E, Gargantini L, Gattei V, Lauria F, Lazzarino M, Mandelli F, Morra, E, Pulsoni A, Ribersani M, Rossi-Ferrini P, Rupolo, M, Tura S, Zagonel V, Zaja F, Zinzani P, Reato G, Foa R (2002) Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood 99:856-862
22. Soubeyran P, Hostein I, Debled M, Eghbali H, Soubeyran I, Bonichon F, Astier-Gin T, Hoerni B (1999) Evolution of bcl-2/IgH hybrid gene RNA expression during treatment of t(14;18)-bearing follicular lymphomas. Br J Cancer 81:860-869
23. Tsimberidou A, McLaughlin P, Younes A, Rodriguez M, Hagemeister F, Sarris A, Romaguera, J, Hess M, Smith T, Yang Y, Ayala A, Preti A, Lee M-S, Cabanillas F (2002) Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma. Blood 100:4351-4357
24. Tsujimoto Y, Finger L, Yunis J, Nowell P, Croce C (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097-1099
25. Yunis J, Frizzera G, Oken M, McKenna J, Theologides A, Arnesen M (1987) Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 316:79-84
26. Zelenetz A, Chen T, Levy R (1991) Histologic transformation of follicular lymphoma to diffuse lymphoma, represents tumor progression by a single malignant B cell. J Exp Med 173:197-207